Overview
- From April 2026, GP practices in England will receive roughly £3,000 a year for prescribing Mounjaro to eligible patients, with about £1,000 more for referrals to weight management services.
- The incentive applies to Mounjaro only, while Wegovy remains delivered through specialist NHS weight-loss services rather than routine GP prescribing.
- Current NHS eligibility stays narrow, with access typically limited to people with very high BMI and weight-related conditions under a long, staged rollout.
- NHS England plans to prioritise about 220,000 patients in the first three years of a programme expected to extend over up to 12 years.
- Ministers cite slow take-up in some surgeries and heavy private use of GLP-1 jabs, as medical bodies warn workload, capacity and the need for sustained lifestyle support constrain rapid expansion.